Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

Translation levels control multi-spanning membrane protein expression.

Kim HS, Ernst JA, Brown C, Bostrom J, Fuh G, Lee CV, Huang A, Vandlen RL, Yansura DG.

PLoS One. 2012;7(4):e35844. doi: 10.1371/journal.pone.0035844. Epub 2012 Apr 26.

2.

Isolation and characterization of the B-cell marker CD20.

Ernst JA, Li H, Kim HS, Nakamura GR, Yansura DG, Vandlen RL.

Biochemistry. 2005 Nov 22;44(46):15150-8.

PMID:
16285718
3.

Novel non-isotopic method for the localization of receptors in tissue sections.

Desnoyers L, Simonette RA, Vandlen RL, Fendly BM.

J Histochem Cytochem. 2001 Dec;49(12):1509-18.

PMID:
11724898
4.

IL-17E, a novel proinflammatory ligand for the IL-17 receptor homolog IL-17Rh1.

Lee J, Ho WH, Maruoka M, Corpuz RT, Baldwin DT, Foster JS, Goddard AD, Yansura DG, Vandlen RL, Wood WI, Gurney AL.

J Biol Chem. 2001 Jan 12;276(2):1660-4.

5.

Structural basis for the binding specificity of a SSTR1-selective analog of somatostatin.

Chen L, Hoeger C, Rivier J, Fitzpatrick VD, Vandlen RL, Tashjian AH Jr.

Biochem Biophys Res Commun. 1999 May 19;258(3):689-94.

PMID:
10329447
6.

Formation of a high affinity heregulin binding site using the soluble extracellular domains of ErbB2 with ErbB3 or ErbB4.

Fitzpatrick VD, Pisacane PI, Vandlen RL, Sliwkowski MX.

FEBS Lett. 1998 Jul 10;431(1):102-6.

7.

Both overlapping and distinct signaling pathways for somatostatin receptor subtypes SSTR1 and SSTR2 in pituitary cells.

Chen L, Fitzpatrick VD, Vandlen RL, Tashjian AH Jr.

J Biol Chem. 1997 Jul 25;272(30):18666-72.

8.

In vivo biological effects of various forms of thrombopoietin in a murine model of transient pancytopenia.

Thomas GR, Thibodeaux H, Errett CJ, Mathias J, Marian M, Meng G, Vandlen RL, Eaton DL.

Stem Cells. 1996;14 Suppl 1:246-55.

9.

6agonist selectivity determinants in somatostatin receptor subtypes I and II.

Fitzpatrick VD, Vandlen RL.

J Biol Chem. 1994 Oct 7;269(40):24621-6.

10.

Coexpression of erbB2 and erbB3 proteins reconstitutes a high affinity receptor for heregulin.

Sliwkowski MX, Schaefer G, Akita RW, Lofgren JA, Fitzpatrick VD, Nuijens A, Fendly BM, Cerione RA, Vandlen RL, Carraway KL 3rd.

J Biol Chem. 1994 May 20;269(20):14661-5.

11.

The erbB3 gene product is a receptor for heregulin.

Carraway KL 3rd, Sliwkowski MX, Akita R, Platko JV, Guy PM, Nuijens A, Diamonti AJ, Vandlen RL, Cantley LC, Cerione RA.

J Biol Chem. 1994 May 13;269(19):14303-6.

12.

Structural characterization by mass spectrometry of native and recombinant human relaxin.

Stults JT, Bourell JH, Canova-Davis E, Ling VT, Laramee GR, Winslow JW, Griffin PR, Rinderknecht E, Vandlen RL.

Biomed Environ Mass Spectrom. 1990 Nov;19(11):655-64.

PMID:
2076464
13.

Preparation of biologically active 32P-labeled human relaxin. Displaceable binding to rat uterus, cervix, and brain.

Osheroff PL, Ling VT, Vandlen RL, Cronin MJ, Lofgren JA.

J Biol Chem. 1990 Jun 5;265(16):9396-401.

14.

Quantitation of urinary somatomedin-C and growth hormone in preterm and fullterm infants and normal children.

Quattrin T, Albini CH, Cara JF, Vandlen RL, Mills BJ, MacGillivray MH.

J Clin Endocrinol Metab. 1988 Apr;66(4):792-7.

PMID:
3346357
15.

Quantitation of urinary growth hormone in children with normal and abnormal growth.

Albini CH, Quattrin T, Vandlen RL, MacGillivray MH.

Pediatr Res. 1988 Jan;23(1):89-92.

PMID:
3340452
16.

Quantitation of urinary somatomedin-C in children with normal and abnormal growth.

Quattrin T, Albini CH, Vandlen RL, MacGillivray MH.

J Clin Endocrinol Metab. 1987 Dec;65(6):1168-71.

PMID:
3680479
17.

Molecular characteristics of receptors for atrial natriuretic factor.

Vandlen RL, Arcuri KE, Hupe L, Keegan ME, Napier MA.

Fed Proc. 1986 Aug;45(9):2366-70. Review.

PMID:
3015690
18.

Binding and internalization of atrial natriuretic factor by high-affinity receptors in A10 smooth muscle cells.

Napier MA, Arcuri KE, Vandlen RL.

Arch Biochem Biophys. 1986 Aug 1;248(2):516-22.

PMID:
2874770
19.
20.

Calcium currents in GH3 cultured pituitary cells under whole-cell voltage-clamp: inhibition by voltage-dependent potassium currents.

Barros F, Katz GM, Kaczorowski GJ, Vandlen RL, Reuben JP.

Proc Natl Acad Sci U S A. 1985 Feb;82(4):1108-12.

21.

Pharmacology and receptor binding of atrial natriuretic factor in vascular smooth muscle.

Winquist RJ, Napier MA, Vandlen RL, Arcuri K, Keegan ME, Faison EP, Baskin EP.

Clin Exp Hypertens A. 1985;7(5-6):869-86.

PMID:
2990774
22.

Specific membrane receptors for atrial natriuretic factor in renal and vascular tissues.

Napier MA, Vandlen RL, Albers-Schönberg G, Nutt RF, Brady S, Lyle T, Winquist R, Faison EP, Heinel LA, Blaine EH.

Proc Natl Acad Sci U S A. 1984 Oct;81(19):5946-50.

23.

Mechanisms of Ca2+ transport in plasma membrane vesicles prepared from cultured pituitary cells. I. Characterization of Na+/Ca2+ exchange activity.

Kaczorowski GJ, Costello L, Dethmers J, Trumble MJ, Vandlen RL.

J Biol Chem. 1984 Aug 10;259(15):9395-403.

24.
25.

Modulation of fertilization by the vitellus after interaction with peptides released by hamster sperm-zona pellucida contact.

Hartmann JF, Hutchison CF, Vandlen RL.

Dev Biol. 1982 Sep;93(1):145-51. No abstract available.

PMID:
6897048
26.

Purification and characterization of plasma membrane fractions from cultured pituitary glands.

Vandlen RL, Sarcione SL, Telakowski CA.

Biochim Biophys Acta. 1981 Dec 21;649(3):595-607.

PMID:
6274405
27.

Studies of the composition of purified Torpedo californica acetylcholine receptor and of its subunits.

Vandlen RL, Wu WC, Eisenach JC, Raftery MA.

Biochemistry. 1979 May 15;18(10):1845-54.

PMID:
435447
28.

Characterization of Torpedo californica acetylcholine receptor: its subunit composition and ligand-binding properties.

Raftery MA, Vandlen RL, Reed KL, Lee T.

Cold Spring Harb Symp Quant Biol. 1976;40:193-202. No abstract available.

PMID:
1065525
29.

Preferential chemical modification of a binding subsite on the acetylcholine receptor.

Chao Y, Vandlen RL, Raftery MA.

Biochem Biophys Res Commun. 1975 Mar 3;63(1):300-7. No abstract available.

PMID:
1125020
30.

Changes in the tertiary structure of alpha-chymotrypsin with change in pH: p4 4.2-6.7.

Vandlen RL, Tulinsky A.

Biochemistry. 1973 Oct 9;12(21):4193-200. No abstract available.

PMID:
4745667
31.

Variability in the tertiary structure of alpha-chymotrypsin at 2.8-A resolution.

Tulinsky A, Vandlen RL, Morimoto CN, Mani NV, Wright LH.

Biochemistry. 1973 Oct 9;12(21):4185-92. No abstract available.

PMID:
4745666
32.

Confirmation of a trimeric subunit arrangement for 2-keto-3-deoxy-6-phosphogluconic aldolase using x-ray crystallographic methods.

Vandlen RL, Ersfeld DL, Tulinsky A, Wood WA.

J Biol Chem. 1973 Mar 25;248(6):2251-3. No abstract available.

Supplemental Content

Loading ...
Support Center